Skip to main content
Fig. 10 | Stem Cell Research & Therapy

Fig. 10

From: Therapeutic effect and safety of stem cell therapy for chronic liver disease: a systematic review and meta-analysis of randomized controlled trials

Fig. 10

Subgroup analyses by the liver disease type, cell type, delivery route, and frequency of administration. Red indicates a significant improvement in the stem cell therapy group compared with the conventional treatment group; blue indicates no significant improvement. CLD chronic liver disease, ACLF acute-on-chronic liver failure, BM-MSC bone marrow-derived mesenchymal stem cell, UC-MSC umbilical cord-derived mesenchymal stem cell, BM-MNC bone marrow-derived mononuclear stem cell

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512